Clinical trial Recruiting at 1 site Observational Ages 18 to 55

Donor ankle sensorimotor recovery after ACL reconstruction with a peroneus longus graft

Official title: Recovery of Donor Ankle Sensorimotor Function Following Anterior Cruciate Ligament Reconstruction Using Peroneus Longus Tendon Autograft: A Prospective Longitudinal Study

Run by Gazi University · NCT07762989 · Data updated 2026-11-12

This study tests how the donor ankle recovers sensorimotor function after ACL reconstruction using a peroneus longus tendon autograft in adults 18–55.

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexAll
Enrollment20 (estimated)
SponsorGazi University
Academic / other
Locations1 site (Çankaya, Ankara)
StatusRecruiting
StartedAugust 22, 2026
Main results expectedAugust 1, 2027
Study endsOctober 1, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07762989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–55 who underwent unilateral ACL reconstruction with a peroneus longus tendon autograft and are referred to the Gazi University Sports Health Unit.

Probably not a fit

Patients who did not receive a peroneus longus autograft or those with complicating factors such as multiligament injuries or pre-existing ankle pathology may see no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study follows 20 adults who had ACL reconstruction with a peroneus longus tendon autograft, assessing donor-ankle sensorimotor function at 6-8 weeks, 3 months, and 6 months postoperatively. Within-subject comparisons between the donor ankle and the opposite ankle will use surface electromyography of the peroneus longus, force-plattform postural control tests, gait analysis with inertial sensors, ankle joint-position sense testing, and patient-reported foot and ankle outcomes. The study does not assign surgical or rehabilitation interventions and aims to describe the natural course of donor-site recovery using objective measurements. Data will inform how donor-site function evolves over time and whether measurable deficits persist or resolve during the first six post-op months.

Why it matters

Potential benefit: If successful, the findings could clarify donor-site recovery trajectories and inform rehabilitation strategies to optimize donor ankle function after ACL reconstruction.

How similar studies have gone: Previous work has described donor-site outcomes in similar graft contexts but longitudinal, objective donor-ankle sensorimotor data over 6 months is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 55 years.
* Unilateral primary anterior cruciate ligament tear confirmed by clinical examination and magnetic resonance imaging.
* Primary anterior cruciate ligament reconstruction performed using a peroneus longus tendon autograft.
* Able and willing to attend the postoperative assessments at 6-8 weeks, 3 months, and 6 months.
* Written informed consent provided before study participation.

Exclusion Criteria:

* Multiligament knee injury.
* Previous surgery on the index knee or donor ankle.
* Pre-existing ankle instability or major foot or ankle pathology.
* Neurological or neuromuscular disease.
* Inflammatory or systemic disease that may affect the assessments.
* Major lower-extremity deformity that may affect the assessments.
* Unable to complete the postoperative rehabilitation program or scheduled follow-up assessments.

Where it's running

  • Gazi University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Sports Health Unit
    Çankaya, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.